Market Update: Amgen Inc (NASDAQ:AMGN) – Amgen Announces Launch Of New Neulasta® (Pegfilgrastim) Delivery Kit

[PR Newswire] – THOUSAND OAKS, Calif., March 2, 2015 /PRNewswire/ — Amgen (AMGN) today announced that the Neulasta® (pegfilgrastim) Delivery Kit is now available in the United States (U.S.). The Neulasta Delivery Kit . . . → Read More: Market Update: Amgen Inc (NASDAQ:AMGN) – Amgen Announces Launch Of New Neulasta® (Pegfilgrastim) Delivery Kit Similar Articles: Stock Update (NASDAQ:AMGN): Amgen Announces The European Medicines Agency Acceptance Of Kyprolis® (Carfilzomib) Marketing Authorization Application For The Treatment Of Relapsed Multiple Myeloma Company Update (NASDAQ:AMGN): Amgen To Present At The Jefferies Global Healthcare Conference Stock Update (NASDAQ:AMGN): The Amgen Foundation Expands Amgen Scholars Program to 17 Top Educational Institutions Worldwide